Trial Profile
Electronic Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia: An International Prospective Observational Study (eAQUA).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Mar 2017
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Acronyms eAQUA
- Sponsors Amgen
- 28 Apr 2014 New source identified and integrated (German Clinical Trials Register: DRKS00005550)
- 17 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.